The added targets generally correlate with larger weight reductions in trials
Author HealthCert Education As GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) become more widely prescribed for type 2 diabetes and weight management, general practitioners are increasingly likely to encounter patients experiencing gut-related side effects
Wegovy Results (STEP-1 Trial) The STEP-1 trial examined 1,961 adults with obesity or overweight over 68 weeks
Saunders shared
Semaglutide is a GLP-1 receptorbased therapy that works through pathways involved in appetite regulation, digestion, and glucose metabolism
Contact your doctor or seek emergency care if you experience: Severe abdominal pain: Especially if it persists and radiates to your back Signs of pancreatitis: Severe stomach pain with nausea and vomiting Severe dehydration: Inability to keep fluids down, dizziness when standing Allergic reactions: Rash, difficulty breathing, or swelling Signs of gallbladder problems: Severe pain in the upper right abdomen Sudden vision changes: This is characterized by rapid vision loss or changes Suicidal thoughts or mood changes: New or worsening depression or severe, unusual behavioral changes Dont hesitate to reach out to your healthcare provider with questions or concerns about side effects, even if they seem minor
